Early in mammalian development, the stem cell leukemia (SCL/TAL1) gene and its distinct 3 0 enhancer (SCL 3 0 En) specify bipotential progenitor cells that give rise to blood and endothelium, thus termed hemangioblasts. We have previously detected a minor population of SCL ( þ ) cells in the postnatal kidney. Here, we demonstrate that cells expressing the SCL 3 0 En in the adult kidney are comprised of CD45 þ CD31À hematopoietic cells, CD45ÀCD31 þ endothelial cells and CD45ÀCD31À interstitial cells. Creation of bone marrow chimeras of SCL 3 0 En transgenic mice into wild-type hosts shows that all three types of SCL 3 0 En-expressing cells in the adult kidney can originate from the bone marrow. Ischemia/ reperfusion injury to the adult kidney of SCL 3 0 En transgenic mice results in the intrarenal elevation of SCL and FLK1 mRNA levels and of cells expressing hem-endothelial progenitor markers (CD45, CD34, c-Kit and FLK1). Furthermore, analysis of SCL 3 0 En in the ischemic kidneys reveals an increase in the abundance of SCL 3 0 En-expressing cells, predominantly within the CD45 ( þ ) hematopoietic fraction and to a lesser extent in the CD45 (À) fraction. Our results suggest organ-injury-induced reactivation of bone marrow-derived hemangioblasts and possible local angioblastic progenitors expressing SCL and SCL 3 0 En.